These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8911587)

  • 21. Experience with clonidine-naltrexone for rapid opiate detoxification.
    Senft RA
    J Subst Abuse Treat; 1991; 8(4):257-9. PubMed ID: 1787550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
    Grüsser SM; Thalemann CN; Platz W; Gölz J; Partecke G
    Biol Psychol; 2006 Mar; 71(3):231-5. PubMed ID: 16046046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].
    Yang G; Zhou W; Xu K
    Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):679-82. PubMed ID: 11715458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets.
    Hamilton RJ; Olmedo RE; Shah S; Hung OL; Howland MA; Perrone J; Nelson LS; Lewin NL; Hoffman RS
    Acad Emerg Med; 2002 Jan; 9(1):63-8. PubMed ID: 11772672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.
    Naderi-Heiden A; Naderi A; Naderi MM; Rahmani-Didar F; Salimi AR; Gleiss A; Kasper S; Frey R
    Pharmacopsychiatry; 2010 Jun; 43(4):130-7. PubMed ID: 20101570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antagonist-induced opiate detoxification. Report on clinical experience as well as on short and intermediate range course].
    Boehle C; Kindgen-Milles D; Burtscheidt W; Tarnow J; Gaebel W
    Nervenarzt; 2000 Sep; 71(9):745-50. PubMed ID: 11042870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anesthesia-assisted opiate detoxification.
    Gevirtz C
    Int Anesthesiol Clin; 2003; 41(2):79-93. PubMed ID: 12711916
    [No Abstract]   [Full Text] [Related]  

  • 28. A possible role for implantable naltrexone in the management of the high-risk pregnant heroin user.
    Hulse GK; O'Neill G
    Aust N Z J Obstet Gynaecol; 2002 Feb; 42(1):93-4. PubMed ID: 11926651
    [No Abstract]   [Full Text] [Related]  

  • 29. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of symptom withdrawal severity in a 24-hour period after the anesthesia-assisted rapid opiate detoxification procedure.
    Teplin D; Raz B; Daiter J; Varenbut M; Zachos CT; Whang P; Herman S; Chaudry S; Yung M
    Am J Drug Alcohol Abuse; 2005; 31(2):327-35. PubMed ID: 15912719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Opiate withdrawal in anesthesia (forced narcotic withdrawal, "turbo withdrawal") in narcotic dependence. Changes in withdrawal treatment--wishes and reality].
    Dettling M; Tretter F
    Nervenarzt; 1996 Sep; 67(9):805-10. PubMed ID: 8992381
    [No Abstract]   [Full Text] [Related]  

  • 32. Ultra-rapid opioid detoxification increases spontaneous ventilation.
    Hoffman WE; Berkowitz R; McDonald T; Hass F
    J Clin Anesth; 1998 Aug; 10(5):372-6. PubMed ID: 9702615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
    J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shortening anesthesia duration does not affect severity of withdrawal syndrome in patients undergoing ultra rapid opioid detoxification.
    Nasseri K; Ahsan B; Farhadifar F; Shami S
    Acta Med Iran; 2010; 48(1):27-32. PubMed ID: 21137665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation.
    Legarda JJ; Gossop M
    Drug Alcohol Depend; 1994 Apr; 35(2):91-3. PubMed ID: 8055740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutical potentialities of rapid opioid detoxification].
    Sivolap IuP
    Anesteziol Reanimatol; 2002; (6):55-8. PubMed ID: 12611160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haight-Ashbury free clinics' drug detoxification protocols--Part 2: Opioid blockade.
    Galloway G; Hayner G
    J Psychoactive Drugs; 1993; 25(3):251-2. PubMed ID: 8258763
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
    Arnold-Reed DE; O'Neil P; Holman CD; Bulsara MK; Rodiguez C; Gawthorne G; Tait RJ; Hulse GK
    Am J Drug Alcohol Abuse; 2007; 33(5):655-64. PubMed ID: 17891658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Add-on gabapentin in the treatment of opiate withdrawal.
    Martínez-Raga J; Sabater A; Perez-Galvez B; Castellano M; Cervera G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):599-601. PubMed ID: 15093968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.